FDG PET/MRI of Acute Myocarditis After mRNA COVID-19 Vaccination

Clin Nucl Med. 2022 May 1;47(5):e421-e422. doi: 10.1097/RLU.0000000000004123.

Abstract

A 22-year-old man visited the emergency department with chest pain. He had received a second dose of the coronavirus disease 2019 (COVID-19) mRNA (Moderna) vaccine 5 days prior. 18F-FDG PET/MR revealed a focal FDG uptake and late gadolinium enhancement on the basal posterolateral wall of the left ventricle. Myocarditis after a COVID-19 vaccination has been reported predominantly after the second dose of mRNA vaccines in young men. This was a case of acute focal myocarditis after a COVID-19 mRNA vaccination, which was well-visualized by FDG PET/MRI.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Contrast Media
  • Fluorodeoxyglucose F18
  • Gadolinium
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Myocarditis* / diagnostic imaging
  • Myocarditis* / etiology
  • RNA, Messenger
  • Vaccination
  • Young Adult

Substances

  • COVID-19 Vaccines
  • Contrast Media
  • RNA, Messenger
  • Fluorodeoxyglucose F18
  • Gadolinium